# Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

> **NCT06423781** · PHASE2 · COMPLETED · sponsor: **Biohaven Therapeutics Ltd.** · enrollment: 233 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** BHV-7000

## Key facts

- **NCT ID:** NCT06423781
- **Lead sponsor:** Biohaven Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2026-03-18
- **Final completion:** 2026-03-18
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423781, "Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06423781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*